These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28316642)

  • 1. Erratum to: New spectrofluorimetric methods for determination of melatonin in the presence of
    Darwish HW; Attia MI; Zlotos DP
    Chem Cent J; 2016; 10():57. PubMed ID: 28316642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]- ethyl}acetamide: a contaminant in commercial melatonin preparations.
    Darwish HW; Attia MI
    Chem Cent J; 2012 May; 6(1):36. PubMed ID: 22551394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative ANNs with different input layers and GA-PLS study for simultaneous spectrofluorimetric determination of melatonin and pyridoxine HCl in the presence of melatonin’s main impurity.
    Darwish HW; Attia MI; Abdelhameed AS; Alanazi AM; Bakheit AH
    Molecules; 2013 Jan; 18(1):974-96. PubMed ID: 23344205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new ferulic/lipoic/comenic acid-melatonin hybrids as antioxidants and Nrf2 activators via Ugi reaction.
    Pachón-Angona I; Martin H; Chhor S; Oset-Gasque MJ; Refouvelet B; Marco-Contelles J; Ismaili L
    Future Med Chem; 2019 Dec; 11(24):3097-3108. PubMed ID: 31838896
    [No Abstract]   [Full Text] [Related]  

  • 5. Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.
    El Kazzouli S; Griffon du Bellay A; Berteina-Raboin S; Delagrange P; Caignard DH; Guillaumet G
    Eur J Med Chem; 2011 Sep; 46(9):4252-7. PubMed ID: 21764185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds.
    Păunescu E; McArthur S; Soudani M; Scopelliti R; Dyson PJ
    Inorg Chem; 2016 Feb; 55(4):1788-808. PubMed ID: 26824462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy.
    Vakkuri O; Lämsä E; Rahkamaa E; Ruotsalainen H; Leppäluoto J
    Anal Biochem; 1984 Nov; 142(2):284-9. PubMed ID: 6549370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite.
    Agozzino P; Avellone G; Bongiorno D; Ceraulo L; Filizzola F; Natoli MC; Livrea MA; Tesoriere L
    J Pineal Res; 2003 Nov; 35(4):269-75. PubMed ID: 14521633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of preparations of (1H-indol-3-yl)methyl electrophiles and development of their microflow rapid generation and substitution.
    Masui H; Kanda S; Fuse S
    Commun Chem; 2023 Mar; 6(1):47. PubMed ID: 36871078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
    Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
    Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
    J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
    Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
    J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
    Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
    Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
    Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
    J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new tricyclic melatoninergic ligands.
    Tsotinis A; Panoussopoulou M; Sivananthan S; Sugden D
    Farmaco; 2001 Sep; 56(9):725-9. PubMed ID: 11680819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
    Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
    Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new indole alkaloid from
    Tie Q; Wang M; Huang X; Chen Y; Liu Y; Yang B; Li Y
    Nat Prod Res; 2023 Sep; ():1-4. PubMed ID: 37746840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol.
    Yoon KS; Lee JM; Kim YH; Suh SK; Cha HJ
    Toxicol Lett; 2020 Feb; 319():40-48. PubMed ID: 31706004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, characterization and synthesis of impurities of zafirlukast.
    Goverdhan G; Reddy AR; Srinivas K; Himabindu V; Reddy GM
    J Pharm Biomed Anal; 2009 May; 49(4):895-900. PubMed ID: 19231127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.